Home › Products › Oncology › Ninlib 150mg Capsule
Ninlib 150mg Capsule
Salt Composition: NILOTINIB
- Manufacturer: HETERO HEALTHCARE LTD
- Pack Size: 30 CAPSULE(s) IN A BOTTLE
- Dosage Form: CAPSULE
- Strength: 150MG
- Prescription Required
- Storage: Keep this medicine out of the sight and reach of children and pets Do not store above 30°C Keep it in its original packaging in order to protect it from light and moisture. During treatment, you may also have a high level of liver enzymes, urea, or insulin. Contact your doctor immediately if you experience any unusual symptoms.
₹2470.00₹3800.00
Inclusive of all taxes
Product Introduction
Ninlib 150mg capsule is an antineoplastic medication containing nilotinib, a tyrosine kinase inhibitor. It is indicated for treating Philadelphia chromosome-positive chronic myeloid leukaemia (Ph-positive CML) in adult and paediatric patients, including those newly diagnosed with chronic myeloid leukaemia (CML) and those who have experienced adverse effects from prior treatment. The medicine is also used in patients who no longer respond to previous treatment, including imatinib.
Do not take this medicine if you are allergic to nilotinib or any other ingredients in the formulation. Inform your doctor if you have a history of cardiac conditions (myocardial infarction, arrhythmia), angina, cerebrovascular accident, or claudication. Notify your doctor of any liver or pancreatic disorders, or deficiencies of potassium or magnesium. Disclose all medications you are taking, particularly those used to lower blood cholesterol. Inform your doctor of any hepatitis B infection history, as this medicine may reactivate hepatitis B, which can be fatal in certain cases. Avoid grapefruit and grapefruit juice during treatment. Inform your doctor if you have lactose intolerance, as this medicine contains lactose.
During treatment, your doctor may perform regular blood tests to monitor liver and pancreatic function, and blood cell counts (WBC, RBC, platelets). Monitoring will also include cardiac assessment (QT interval prolongation), electrolyte levels, and glucose and lipid profiles to evaluate how well Ninlib 150mg is tolerated. Inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding. Use effective contraception during treatment with this medicine.
Uses
Blood cancer (Philadelphia chromosome-positive chronic myeloid leukemia) in adults and pediatrics.
How it works
BCR-ABL tyrosine kinase is responsible for the uncontrolled division of cells in the CML. Ninlib 150mg disrupts the signaling route of the protein kinase enzyme which targets the BCR-ABL protein and inhibits the growth and spread of cancer cells.
How to Use
Take Ninlib 150mg as advised by your physician. Swallow the medicine with a glass of water. Do not crush, chew, or open the medicine. Your doctor will decide the correct dose and duration for you based on your age, body weight, and disease condition. Do not stop taking Ninlib 150mg unless your doctor advises you to stop.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Sudden weight gain Swelling in hands, feet, ankles, or face Chest pain Blood pressure (high and low) Discoloration of tongue, lips, or skin (blue) Abnormal heart (irregular heartbeat) Hair loss Vision problem Stomach pain, vomiting of blood, blood in stools. Yellowing of the skin, eyes, and dark urine. High blood sugar levels. Sensitivity to light Common Nausea, vomiting, diarrhoea. Headache, muscle pain, stomach pain. Hair loss. Tiredness. Constipation. Slowing of growth in children. Pneumonia. Loss of appetite. Sleeplessness, depression, and anxiety. Stomach discomforts like bloating and flatulence after meals. musculoskeletal pain
Expert Tips
Based on your condition your doctor may prescribe a lower dose. Ninlib 150mg can be used by people aged 65 years and over with the same dose as other adults. Tell your doctor if you experience any irregular heartbeats or any signs of a heart condition because this can lead to serious complications like sudden death. Inform your physician if you have kidney problems. Your physician will decide whether you may receive this medication after monitoring your kidney functions. Some children and adolescents taking this medicine may have slower than normal growth. So, your doctor will regularly monitor your growth. Report to your doctor if you have had a history of heart failure or hepatitis infection. Discuss effective contraceptive options with your healthcare provider.
References
- Robert J. Thomson; Majid Moshirfar; Yasmyne Ronquillo; Tyrosine Kinase Inhibitors, [Revised on 21st Jan 2021]; [Accessed on 22st April 2023]; https://www.ncbi.nlm.nih.gov/books/NBK563322/
- Novartis Pharmaceuticals UK Ltd, Electronic Medicines Compendium (EMC), [Revised on May 2022], [Accessed on 21st April 2023], https://www.medicines.org.uk/emc/product/5852
- Novartis, US Food & Drug Administration, [Revised on Sep 2021], [Accessed on 21st April 2023], https://www.novartis.us/sites/www.novartis.us/files/tasigna.pdf
Safety Advice
Pregnancy: unsafe Ninlib 150mg is unsafe to use during pregnancy unless it is necessary. Report to your doctor if you are pregnant or think you may be pregnant, or planning for the pregnancy before starting the treatment; your doctor will tell you whether you can take this medicine during your pregnancy.
Lungs: Consult your doctor It is unknown if patients with lung conditions can consume Ninlib 150mg. So, before beginning the treatment, consult your doctor if you have any lung conditions. Consult your doctor if you experience symptoms like difficulty in breathing, wheezing or any other lung related condition while taking Ninlib 150mg.
Breastfeeding: unsafe Taking Ninlib 150mg while breastfeeding may be unsafe because it may affect the child. Therefore, talk with your doctor to get more information.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.